春立医疗 (688236.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

12.1x

Market Cap

CNY 5.46B

MomentumView details →

1D Return

−1.73%

YTD Return

—

RSI (14)

45.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

12.1x

Market Cap

CNY 5.46B

RSI (14)

45.5

MomentumView details →

1D Return

−1.73%

YTD Return

—

ProfitabilityView details →

Gross Margin

65.94%

Net Margin

26.74%

EBITDA Margin

33.09%

ROE (TTM)

9.06%

ROA (TTM)

7.60%

Asset Turnover

0.28x

GrowthView details →

Revenue YoY

+26.91%

EPS YoY

+114.87%

FCF YoY

—

Revenue CAGR 3Y

−4.52%

EPS CAGR 3Y

−3.90%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.15

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

6.09x

Quick Ratio

4.98x

Div Yield

1.06%

Div Rate

CNY 0.15

Div Growth 1Y

+206.12%

Financials snapshotView financials →

Revenue (TTM)

1.03B

Net Income (TTM)

276.18M

Op. CF (TTM)

469.26M

Next earningsNov 4, 2026 →

Latest newsMore news →

Chunli Medical proposed a cash dividend of 1.30 yuan per 10 shares (tax inclusive), with total payout representing 41.42% of consolidated net profit attributable to shareholders, subject to shareholder approval.7d ago

Chunli Medical announced its 2026 half-year results with revenue of 417 million yuan, down 14.46% year-on-year, and net profit attributable to shareholders of 120 million yuan, up 4.79% year-on-year.7d ago

Similar companies

AK Medical Holdings Limited01789.HK 浩欧博688656.SH LifeTech Scientific Corporation01302.HK China Isotope & Radiation Corporation01763.HK 三友医疗688085.SH 基蛋生物603387.SH Find similar companies →

Latest newsMore news →

Chunli Medical proposed a cash dividend of 1.30 yuan per 10 shares (tax inclusive), with total payout representing 41.42% of consolidated net profit attributable to shareholders, subject to shareholder approval.7d ago Chunli Medical announced its 2026 half-year results with revenue of 417 million yuan, down 14.46% year-on-year, and net profit attributable to shareholders of 120 million yuan, up 4.79% year-on-year.7d ago